相关实验视频

Updated: May 24, 2025

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

功能性脂基纳米药物作为器官特定输送药物载体的最新进展

Yeochan Yun¹, Jeongmin An¹, Hyun Joong Kim¹

¹Department of Bio & Fermentation Convergence Technology, Kookmin University, Seoul 02707, Republic of Korea. chohy@kookmin.ac.kr.

|March 3, 2025

概括

基于脂质的纳米粒子为遗传材料提供先进的药物输送. 带功能化纳米颗粒改善了器官向,提高了治疗效率并减少了副作用.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
药理学药理学是指药理学的学科.

背景情况:

基于脂质的纳米粒子 (LBNS) 是诸如mRNA和等离子体等治疗剂的多功能载体.
目前面临的挑战包括药物泄漏,溶解性差,缺乏向特异性.
需要取得进展,以提高药物的有效性和减少药物输送中的不良影响.

研究的目的:

审查基于脂质的纳米粒子药物输送系统.
探索使用带功能化纳米粒子进行器官特异性输送.
讨论基于脂质的纳米药物的挑战和未来方向.

主要方法:

对脂质体,脂质纳米粒子配方,固体脂质纳米粒子和纳米乳液进行了全面的审查.
对带功能化纳米粒子进行针对性器官输送的研究.
分析最近基于脂质的纳米药物 (LBNs) 的进展.

主要成果:

带功能化的LBN能够直接和高效地将药物输送到目标器官.
与传统方法相比,这种策略导致了优越的DNA或mRNA表达.
新型配体可以最大限度地减少非特异性药物输送的副作用.

结论:

基于脂质的纳米颗粒可以克服目前的药物输送限制.
优化的LBN设计提高了治疗效果,减少了不良影响.
对LBNs的进一步研究有望改善药物输送策略.

更多相关视频

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

相关概念视频

Drug Delivery: Overview

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...